ADP-ribosylation from molecular mechanisms to therapeutic implications

Marcin J Suskiewicz (1) , Evgeniia Prokhorova (2) , Johannes G M Rack (2, 3) , Ivan Ahel (2)

1 CBM - Centre de biophysique moléculaire
2 Sir William Dunn School of Pathology [Oxford]
3 University of Exeter

ADP-ribosylation is a ubiquitous modification of biomolecules, including proteins and nucleic acids, that regulates various cellular functions in all kingdoms of life. The recent emergence of new technologies to study ADP-ribosylation has reshaped our understanding of the molecular mechanisms that govern the establishment, removal, and recognition of this modification, as well as its impact on cellular and organismal function. These advances have also revealed the intricate involvement of ADP-ribosylation in human physiology and pathology and the enormous potential that their manipulation holds for therapy. In this review, we present the state-of-the-art findings covering the work in structural biology, biochemistry, cell biology, and clinical aspects of ADP-ribosylation.

Mots clés: Adp-ribosylation; PARP-1; PARP family

Domaines: Sciences du Vivant [q-bio]

Marcin J Suskiewicz, Evgeniia Prokhorova, Johannes G M Rack, Ivan Ahel. ADP-ribosylation from molecular mechanisms to therapeutic implications. Cell, 2023, 186, pp.4475 - 4495. ⟨10.1016/j.cell.2023.08.030⟩. ⟨hal-04310798⟩